[RPRX] YoY Annual Result on 31-Dec-2020 [#FY]

Stock
[RPRX] Royalty Pharma plc
Announcement Date
24-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#FY]
Profit Trend
YoY- -78.91%
Quarter Report
RPRX's Result
RPRX's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 2,354,554 2,237,215 2,289,463 2,122,000 1,814,254 1,794,894 1,597,930 6.67%
PBT 1,700,088 230,064 1,241,201 1,702,000 2,461,419 1,517,855 1,343,180 4.00%
Tax 0 187,232 762,447 1,147,000 349,333 433,365 542,655 -
NP 1,134,834 42,832 478,754 495,198 2,348,535 1,377,729 1,210,025 -1.06%
Tax Rate 0.00% -81.38% -61.43% -67.39% -14.19% -28.55% -40.40% -
Total Cost 1,219,720 2,194,383 1,810,709 1,626,802 -534,281 417,165 387,905 21.02%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 48.20 1.91 20.91 23.34 129.45 76.76 75.72 -7.24%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 3.41 0.10 1.15 1.32 6.42 3.89 3.42 -0.04%
EPS Diluted 2.53 0.10 1.15 1.32 6.42 3.89 3.42 -4.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.